Study links higher-potency cannabis use in youth to increased risk of psychotic experiences

FHS
May 14, 2024
6:25 pm

Young individuals consuming higher-potency cannabis, such as skunk, between ages 16 and 18, are twice as likely to have psychotic experiences from age 19 to 24 compared to those using lower-potency cannabis.

ESC 2024: Amvuttra data signals positive prospects in cardiomyopathy for Alnylam – Pharmaceutical Technology

Amvuttra showed a significant reduction in mortality and cardiovascular events for ATTR amyloidosis with cardiomyopathy patients in the Helios B trial. Credit: Tada Images via

August 30, 2024

Scientists Show How Pregnancy Changes the Brain in Innumerable Ways

Neuroscientist Liz Chrastil, PhD, got the unique chance to see how her brain changed while she was pregnant and share what she learned in a

September 17, 2024

Delivery and manufacturing hurdles remain in the cell and gene therapy – Pharmaceutical Technology

Share this article The Advanced Therapies 2024 conference in London. Credit: Irena Maragkou/Globaldata. The current prospects and obstacles in the cell and gene therapy space

March 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.